Fermenta Biotech Limited Q2 FY26 results deck summary

Results deck of 12 Nov 2025, summarised by AI from the filing.

H1FY26 revenue ₹280.7 cr, up 57% YoY, with EBITDA ₹69.1 cr and PAT ₹39.6 cr.

Key takeaways

1. H1FY26 revenue Revenue ₹280.7 cr, up 57% YoY, with EBITDA ₹69.1 cr and PAT ₹39.6 cr.
2. Guidance No forward guidance was provided in the presentation.
3. Cash flow Operating cash flow turned positive at ₹38 cr from negative ₹3 cr in H1FY25.
4. Growth driver Human nutrition segment volumes grew 74% over H1FY25, driving revenue growth.

Original filing on BSE

Fermenta Biotech Limited Q1 FY27 results

As filed: Revenue ₹112 cr, EBITDA ₹23.0 cr, PAT ₹15.0 cr, EBITDA margin 20.6%.

Not scored. No result for the same quarter last year.

Fermenta Biotech Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (11 Aug 2026), Results press release (11 Aug 2026)
• Q4 FY26: Results deck (26 May 2026), Results press release (26 May 2026)
• Q3 FY26: Results deck (11 Feb 2026), Results press release (9 Feb 2026)
• Q2 FY26: Results deck (12 Nov 2025), Results press release (11 Nov 2025)
• Q1 FY26: Results deck (13 Aug 2025)
• Q4 FY25: Results deck (4 Jun 2025), Results press release (28 May 2025)